Free Newsletter
GSK's CEO Witty wants U.K. focus on manufacturing
GlaxoSmithKline ($GSK) CEO Andrew Witty (photo) said the U.K. needs to positively rebalance its economy, while growing the private sector with a focus on manufacturing, according to Social Enterprise. But trust in the private sector has eroded, he said, and business leaders have to lead by example in terms of corporate responsibility. Article
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: